Blood Screening Market Size & Share, by Technology (Nucleic Acid Testing, Rapid Tests, Western Blot Assay, ELISA, Next-Generation Sequencing); Product Type (Reagents & Kits, Instruments); End-user (Hospitals, Clinical Laboratories) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4480
  • Published Date: Aug 02, 2023
  • Report Format: PDF, PPT

Blood Screening Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~6%

Base Year Market Size (2022)

~ USD 2.65 Billion

Forecast Year Market Size (2035)

~ USD 5.03 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)


Blood Screening Market
Get more information on this report: Request Free Sample PDF

Blood Screening Sector: Growth Drivers and Challenges

Growth Drivers

  • Higher Need and Contributions to Blood Donation– As healthcare systems improve and the availability and need for complex surgical operations such as cardiology and transplant surgery, trauma treatment, and therapy for cancer and blood illness increase, so does the demand for donated blood. According to the World Health Organization, every year approximately 119 million units of blood are collected worldwide.
  • Increasing Prevalence of HIV and Hepatitis– By the statistics of the Centers for Disease Control and Prevention, around 296 million people worldwide are living with Hepatitis B. In addition, globally around 38 million people have HIV. HIV testing is necessary for persons who are more likely to catch the virus.
  • Increased Penetration of Malaria- The World Health Organisation (WHO) estimates that there are 300-500 million cases of malaria worldwide each year. Blood screening helps in identifying the Plasmodium species and determining parasitic load in the blood

Challenges

  • Lack of Adequate Infrastructure – Proper equipment, electricity, temperature control, and a hygienic environment are required for the effective screening of blood samples. Apart from that, storage of the samples in the right manner is also necessary.
  • Lack of Skilled Manpower
  • Presence of Alternative Technologies

Blood Screening Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~6%

Base Year Market Size (2022)

~ USD 2.65 Billion

Forecast Year Market Size (2035)

~ USD 5.03 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Blood Screening Segmentation

Technology (Nucleic Acid Testing, Rapid Tests, Western Blot Assay, ELISA, Next-Generation Sequencing)

The ELISA segment in the blood screening market is anticipated to hold the largest gain by the end of 2035. ELISA is a typical laboratory test, done to find antibodies in the blood. They are produced when the immune system of the body recognizes dangerous compounds, known as antigens. The segment growth is primarily attributed to the rising need for testing for COVID-19, and carrying out sexually transmitted diseases testing among the population around the world. As per the World Health Organization, globally, more than 1 million people have STDs. Moreover, as of July 2022, there were nearly 40 million HIV cases all over the world.

End Users (Hospitals, Clinical Laboratories)

Blood screening market from the hospital segment is attributed to holding the largest share of 55 % over the forecast period. As a large patient pool is being admitted to hospitals, owing to which the popularity of hospitals is being increased daily, it is anticipated to bring lucrative growth opportunities for the segment growth. Further, the growing cases of organ transplant surgeries in hospitals are other factors to drive the segment growth.

Our in-depth analysis of the global market includes the following segments:

     Technology

  • Nucleic Acid Testing
  • Rapid Tests
  • Western Blot Assay
  • ELISA
  • Next-Generation Sequencing

     Product Type

  • Reagents & Kits
  • Instruments

     End User

  • Hospitals
  • Clinical Laboratories

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Blood Screening Industry- Regional Synopsis

North American Market Forecast

The blood screening market in North America is projected to be the largest with a share of about 38% by the end of 2035. The higher demand for blood transfusion is forecasted to elevate the market growth in North America during the assessment period. Every year, around 21 million blood components are transfused in the United States. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by regulatory bodies, is anticipated to contribute positively to the market's growth.

APAC Market Statistics

The Asia Pacific market is estimated to be the second largest, registering a share of about 25% by the end of 2035. The major factor that is attributed to creating a positive outlook for the market growth is the increasing spending capacity of opting for advanced medical facilities such as blood transfusion diagnostics along with the presence of a high number of medical facilities are also anticipated to hike the market growth further during the projected time frame in the region.

Research Nester
Blood Screening Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Blood Screening Landscape

top-features-companies
    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Grifols, S.A.
    • Quotient Limited
    • Thermo Fisher Scientific Inc.
    • BD
    • Ortho Clinical Diagnostics
    • DiaSorin S.p.A.
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Beckman Coulter, Inc.

In-the-news

In The News

  • Grifols, S.S. announced an agreement with Canadian Blood Services to boost the country’s independence in immunoglobulins medicines and plasma-protein therapies for Canada.
  • Quotient Limited announced the partnership with Theradiag for the development of autoimmune disease diagnostics by integrating it with automatic multiplexed solutions.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4480
  • Published Date: Aug 02, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising number of people suffering with chronic diseases, higher blood transfusions and increased cases of infectious diseases are the major factors driving the market growth.

The market size of blood screening is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Grifols, S.A., Quotient Limited, Thermo Fisher Scientific Inc., BD, Ortho Clinical Diagnostics, DiaSorin S.p.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Beckman Coulter, Inc., and Abbott Laboratories

The ELISA segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Blood Screening Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying